Search Results - "Jeha, Sima S."

Randomized Phase I/II Study of Troxacitabine Combined With Cytarabine, Idarubicin, or Topotecan in Patients With Refractory Myeloid Leukemias by Giles, Francis J, Faderl, Stefan, Thomas, Deborah A, Cortes, Jorge E, Garcia-Manero, Guillermo, Douer, Dan, Levine, Alexandra M, Koller, Charles A, Jeha, Sima S, O'Brien, Susan M, Estey, Elihu H, Kantarjian, Hagop M

“…Troxacitabine has significant single-agent activity. This study was conducted to define the dose-limiting toxicities (DLTs) of its combination with cytarabine…”
Get full text

Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients by Mullen, Craig A., Petropoulos, Demetrios, Roberts, W. Mark, Rytting, Michael, Zipf, Theodore, Chan, Ka Wah, Culbert, Steven J., Danielson, Martha, Jeha, Sima S., Kuttesch, John F., Rolston, Kenneth V.

“…BACKGROUND Fever and neutropenia (F&N) is a common complication of cancer chemotherapy. It is conveniently managed by hospitalization and empiric…”
Get full text

Biologic response modifiers in pediatric cancer by Worth, L L, Jeha, S S, Kleinerman, E S

“…Biologic response modifiers are becoming an important addition to surgery, chemotherapy, and radiotherapy in the management of cancer. As this field of…”
Get more information

Economic and resource utilization analysis of outpatient management of fever and neutropenia in low-risk pediatric patients with cancer by MULLEN, C. A, PETROPOULOS, D, ROLSTON, K. V, ROBERTS, W. M, RYTTING, M, ZIPF, T, CHAN, K. W, CULBERT, S. J, DANIELSON, M, JEHA, S. S, KUTTESCH, J. F

“…To measure resource allocation in outpatient management of fever and neutropenia in low-risk pediatric patients with cancer and its impact on their families. A…”
Get full text

Stimulation of Myelopoiesis in a Patient With Congenital Neutropenia: Biology and Nature of Response to Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor by Vadhan-Raj, Saroj, Jeha, Sima S., Buescher, Stephen, LeMaistre, Ann, Yee, Garland, Lu, Li, Lloreta, Josep, Hoots, William K., Hittelman, Walter N., Gutterman, Jordan U., Broxmeyer, Hal E.

“…To stimulate granulopoiesis, we gave recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF; 120 μg/m2/d) to a patient with congenital…”
Get full text